Main > NEUROLOGY. > Spinal Cord Injury > Treatment. > Clostridium Botulinum C3 Toxin > Co.: CA. B. (Phase II/Patent)

---

Co.: CA. B. (Phase II/Patent)'s subsections
Company
Mechanism: Rho Kinase Inhibition
Patent>Assignee, Claims, No., Etc.
Patent>UpDate: 01.08.08
ReCombinant Fusion Protein
Status >
TradeMark
UpDate: 01.07.08

Co.: CA. B. (Phase II/Patent)'s products
This section has no products